Reaching the poor with health interventions: programme-incidence analysis of seven randomised trials of women's groups to re
PDF-1.3 % 82 0 obj << /Linearized 1 /O 84 /H [ 734 268 ] /L 102244 /E 52292 /N 13 /T 100486 >> endobj xref
![Název projektu OPVK: Podpora výuky a vzdělávání na GVN J. Hradec CZ.1.07/1.5.00/ Klíčová aktivita: V/2 - PDF Free Download Název projektu OPVK: Podpora výuky a vzdělávání na GVN J. Hradec CZ.1.07/1.5.00/ Klíčová aktivita: V/2 - PDF Free Download](http://docplayer.cz/docs-images/54/8646306/images/page_7.jpg)
Název projektu OPVK: Podpora výuky a vzdělávání na GVN J. Hradec CZ.1.07/1.5.00/ Klíčová aktivita: V/2 - PDF Free Download
![Morphologically Different Pectobacterium brasiliense Bacteriophages PP99 and PP101: Deacetylation of O-Polysaccharide by the Tail Spike Protein of Phage PP99 Accompanies the Infection. - Abstract - Europe PMC Morphologically Different Pectobacterium brasiliense Bacteriophages PP99 and PP101: Deacetylation of O-Polysaccharide by the Tail Spike Protein of Phage PP99 Accompanies the Infection. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6989608/bin/fmicb-10-03147-g0005.jpg)
Morphologically Different Pectobacterium brasiliense Bacteriophages PP99 and PP101: Deacetylation of O-Polysaccharide by the Tail Spike Protein of Phage PP99 Accompanies the Infection. - Abstract - Europe PMC
![Solar X-Ray Monitor on Board the Chandrayaan-2 Orbiter: In-Flight Performance and Science Prospects | SpringerLink Solar X-Ray Monitor on Board the Chandrayaan-2 Orbiter: In-Flight Performance and Science Prospects | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11207-020-01712-1/MediaObjects/11207_2020_1712_Fig9_HTML.png)
Solar X-Ray Monitor on Board the Chandrayaan-2 Orbiter: In-Flight Performance and Science Prospects | SpringerLink
![Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Blood Cancer Journal Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-00357-4/MediaObjects/41408_2020_357_Fig1_HTML.png)
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Blood Cancer Journal
![Sonochemical coating of Prussian Blue for the production of smart bacterial-sensing hospital textiles - ScienceDirect Sonochemical coating of Prussian Blue for the production of smart bacterial-sensing hospital textiles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1350417720306507-gr6.jpg)